Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence

Cell Metabolism

Volumn 27, Issue 3, 2018, Pages 529-547

  Rajman, Luis ^a   Chwalek, Karolina ^a   Sinclair, David A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

aging; cancer; cardiovascular disease; CD38; chromatin; epigenetics; inflammation; nicotinamide mononucleotide; nicotinamide riboside; PARP1; sirtuins; STAC

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE;

AGING; CARDIOVASCULAR FUNCTION; DNA REPAIR; HEART FUNCTION; HUMAN; IMMUNITY; IN VIVO STUDY; INFLAMMATION; KIDNEY FUNCTION; LIVER FUNCTION; LONGEVITY; MALIGNANT NEOPLASM; MOLECULE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SYNTHESIS; UPREGULATION; ANIMAL; ENERGY METABOLISM; METABOLISM;

ANIMALS; ENERGY METABOLISM; HUMANS; LONGEVITY; NAD; SIGNAL TRANSDUCTION;

EID: 85042376259     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2018.02.011     Document Type: Review

References (268)

1. Ahn, B.H., Kim, H.S., Song, S., Lee, I.H., Liu, J., Vassilopoulos, A., Deng, C.X., Finkel, T., A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. USA 105 (2008), 14447–14452.
2. Airhart, S.E., Shireman, L.M., Risler, L.J., Anderson, G.D., Nagana Gowda, G.A., Raftery, D., Tian, R., Shen, D.D., O'Brien, K.D., An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One, 12, 2017, e0186459.
3. Aksoy, P., Escande, C., White, T.A., Thompson, M., Soares, S., Benech, J.C., Chini, E.N., Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem. Biophys. Res. Commun. 349 (2006), 353–359.
4. Alano, C.C., Garnier, P., Ying, W., Higashi, Y., Kauppinen, T.M., Swanson, R.A., NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J. Neurosci. 30 (2010), 2967–2978.
5. Aleo, M.F., Giudici, M.L., Sestini, S., Danesi, P., Pompucci, G., Preti, A., Metabolic fate of extracellular NAD in human skin fibroblasts. J. Cell. Biochem. 80 (2001), 360–366.
6. Alisky, J.M., Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash–a case report. Nutr. Neurosci. 8 (2005), 327–329.
7. Almeida, G.S., Bawn, C.M., Galler, M., Wilson, I., Thomas, H.D., Kyle, S., Curtin, N.J., Newell, D.R., Maxwell, R.J., PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS. NMR Biomed., 30, 2017, 10.1002/nbm.3736.
8. Altschul, R., Hoffer, A., Stephen, J.D., Influence of nicotinic acid on serum cholesterol in man. Arch. Biochem. Biophys. 54 (1955), 558–559.
9. Anderson, R.M., Bitterman, K.J., Wood, J.G., Medvedik, O., Cohen, H., Lin, S.S., Manchester, J.K., Gordon, J.I., Sinclair, D.A., Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J. Biol. Chem. 277 (2002), 18881–18890.
10. Anderson, R.M., Bitterman, K.J., Wood, J.G., Medvedik, O., Sinclair, D.A., Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423 (2003), 181–185.
11. Ansari, H.R., Raghava, G.P., Identification of NAD interacting residues in proteins. BMC Bioinformatics, 11, 2010, 160.
12. Araki, T., Sasaki, Y., Milbrandt, J., Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004), 1010–1013.
13. Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F., Mostoslavsky, R., Alt, F.W., Schibler, U., SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134 (2008), 317–328.
14. Audrito, V., Serra, S., Brusa, D., Mazzola, F., Arruga, F., Vaisitti, T., Coscia, M., Maffei, R., Rossi, D., Wang, T., et al. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood 125 (2015), 111–123.
15. Ayoub, I.A., Lee, E.J., Ogilvy, C.S., Beal, M.F., Maynard, K.I., Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats. Neurosci. Lett. 259 (1999), 21–24.
16. Bahn, A., Hagos, Y., Reuter, S., Balen, D., Brzica, H., Krick, W., Burckhardt, B.C., Sabolic, I., Burckhardt, G., Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J. Biol. Chem. 283 (2008), 16332–16341.
17. Bai, P., Biology of Poly(ADP-Ribose) polymerases: The factotums of cell maintenance. Mol. Cell 58 (2015), 947–958.
18. Bai, P., Cantó C., The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab. 16 (2012), 290–295.
19. Bai, P., Houten, S.M., Huber, A., Schreiber, V., Watanabe, M., Kiss, B., de Murcia, G., Auwerx, J., Ménissier-de Murcia, J., Poly(ADP-ribose) polymerase-2 [corrected] controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/peroxisome proliferator-activated receptor-gamma [corrected] heterodimer. J. Biol. Chem. 282 (2007), 37738–37746.
20. Bai, P., Cantó C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R.H., et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13 (2011), 461–468.
21. Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., Kirkland, J.L., van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
22. Balan, V., Miller, G.S., Kaplun, L., Balan, K., Chong, Z.Z., Li, F., Kaplun, A., VanBerkum, M.F., Arking, R., Freeman, D.C., et al. Life span extension and neuronal cell protection by Drosophila nicotinamidase. J. Biol. Chem. 283 (2008), 27810–27819.
23. Barbosa, M.T., Soares, S.M., Novak, C.M., Sinclair, D., Levine, J.A., Aksoy, P., Chini, E.N., The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 21 (2007), 3629–3639.
24. Batra, V., Kislay, B., Mitigation of gamma-radiation induced abasic sites in genomic DNA by dietary nicotinamide supplementation: metabolic up-regulation of NAD(+) biosynthesis. Mutat. Res. 749 (2013), 28–38.
25. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006), 337–342.
26. Belenky, P., Racette, F.G., Bogan, K.L., McClure, J.M., Smith, J.S., Brenner, C., Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell 129 (2007), 473–484.
27. Belenky, P.A., Moga, T.G., Brenner, C., Saccharomyces cerevisiae YOR071C encodes the high affinity nicotinamide riboside transporter Nrt1. J. Biol. Chem. 283 (2008), 8075–8079.
28. Berger, F., Lau, C., Dahlmann, M., Ziegler, M., Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 280 (2005), 36334–36341.
29. Berthelier, V., Tixier, J.M., Muller-Steffner, H., Schuber, F., Deterre, P., Human CD38 is an authentic NAD(P)+ glycohydrolase. Biochem. J. 330 (1998), 1383–1390.
30. Birjmohun, R.S., Hutten, B.A., Kastelein, J.J., Stroes, E.S., Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol. 45 (2005), 185–197.
31. Bitterman, K.J., Anderson, R.M., Cohen, H.Y., Latorre-Esteves, M., Sinclair, D.A., Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277 (2002), 45099–45107.
32. Bock, F.J., Todorova, T.T., Chang, P., RNA regulation by Poly(ADP-Ribose) polymerases. Mol. Cell 58 (2015), 959–969.
33. Bogan, K.L., Brenner, C., Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28 (2008), 115–130.
34. +and sirtuin-activating compounds. Nat. Rev. Mol. Cell Biol. 17 (2016), 679–690.
35. Boslett, J., Hemann, C., Zhao, Y.J., Lee, H.C., Zweier, J.L., Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H). J. Pharmacol. Exp. Ther. 361 (2017), 99–108.
36. + precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab. 20 (2014), 1059–1068.
37. Brown, J.S., Kaye, S.B., Yap, T.A., PARP inhibitors: the race is on. Br. J. Cancer 114 (2016), 713–715.
38. Camacho-Pereira, J., Tarragó M.G., Chini, C.C.S., Nin, V., Escande, C., Warner, G.M., Puranik, A.S., Schoon, R.A., Reid, J.M., Galina, A., Chini, E.N., CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 23 (2016), 1127–1139.
39. +. Science 352 (2016), 1474–1477.
40. Cameron, W.D., Bui, C.V., Hutchinson, A., Loppnau, P., Gräslund, S., Rocheleau, J.V., Apollo-NADP(+): a spectrally tunable family of genetically encoded sensors for NADP(+). Nat. Methods 13 (2016), 352–358.
41. Cantó C., Houtkooper, R.H., Pirinen, E., Youn, D.Y., Oosterveer, M.H., Cen, Y., Fernandez-Marcos, P.J., Yamamoto, H., Andreux, P.A., Cettour-Rose, P., et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15 (2012), 838–847.
42. Cerutti, R., Pirinen, E., Lamperti, C., Marchet, S., Sauve, A.A., Li, W., Leoni, V., Schon, E.A., Dantzer, F., Auwerx, J., et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab. 19 (2014), 1042–1049.
43. Chambon, P., Weill, J.D., Mandel, P., Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 11 (1963), 39–43.
44. Chan, P.K., Torres, R., Yandim, C., Law, P.P., Khadayate, S., Mauri, M., Grosan, C., Chapman-Rothe, N., Giunti, P., Pook, M., Festenstein, R., Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3. Hum. Mol. Genet. 22 (2013), 2662–2675.
45. Chang, P., Coughlin, M., Mitchison, T.J., Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nat. Cell Biol. 7 (2005), 1133–1139.
46. Chang, Y.H., Chang, D.M., Lin, K.C., Shin, S.J., Lee, Y.J., Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab. Res. Rev. 27 (2011), 515–527.
47. Chen, A.C., Damian, D.L., Nicotinamide and the skin. Australas. J. Dermatol. 55 (2014), 169–175.
48. Chen, M.P., Chung, F.M., Chang, D.M., Tsai, J.C., Huang, H.F., Shin, S.J., Lee, Y.J., Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 91 (2006), 295–299.
49. Chi, N.W., Lodish, H.F., Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J. Biol. Chem. 275 (2000), 38437–38444.
50. Chillemi, A., Zaccarello, G., Quarona, V., Ferracin, M., Ghimenti, C., Massaia, M., Horenstein, A.L., Malavasi, F., Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. Mol. Med. 19 (2013), 99–108.
51. Chini, C.C., Guerrico, A.M., Nin, V., Camacho-Pereira, J., Escande, C., Barbosa, M.T., Chini, E.N., Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors. Clin. Cancer Res. 20 (2014), 120–130.
52. Chugani, D.C., Rome, L.H., Kedersha, N.L., Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci. 106 (1993), 23–29.
53. Coleman, M.P., Conforti, L., Buckmaster, E.A., Tarlton, A., Ewing, R.M., Brown, M.C., Lyon, M.F., Perry, V.H., An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc. Natl. Acad. Sci. USA 95 (1998), 9985–9990.
54. Conforti, L., Gilley, J., Coleman, M.P., Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat. Rev. Neurosci. 15 (2014), 394–409.
55. Conze, D.B., Crespo-Barreto, J., Kruger, C.L., Safety assessment of nicotinamide riboside, a form of vitamin B3. Hum. Exp. Toxicol., 2016 Published online January 20, 1016. 0960327115626254.
56. Damian, D.L., Patterson, C.R., Stapelberg, M., Park, J., Barnetson, R.S., Halliday, G.M., UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J. Invest. Dermatol. 128 (2008), 447–454.
57. Daugherty, M.D., Young, J.M., Kerns, J.A., Malik, H.S., Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts. PLoS Genet., 10, 2014, e1004403.
58. De Jesús-Cortés, H., Xu, P., Drawbridge, J., Estill, S.J., Huntington, P., Tran, S., Britt, J., Tesla, R., Morlock, L., Naidoo, J., et al. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. Proc. Natl. Acad. Sci. USA 109 (2012), 17010–17015.
59. de Picciotto, N.E., Gano, L.B., Johnson, L.C., Martens, C.R., Sindler, A.L., Mills, K.F., Imai, S., Seals, D.R., Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 15 (2016), 522–530.
60. Di Stefano, M., Nascimento-Ferreira, I., Orsomando, G., Mori, V., Gilley, J., Brown, R., Janeckova, L., Vargas, M.E., Worrell, L.A., Loreto, A., et al. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ. 22 (2015), 731–742.
61. Di Stefano, M., Loreto, A., Orsomando, G., Mori, V., Zamporlini, F., Hulse, R.P., Webster, J., Donaldson, L.F., Gering, M., Raffaelli, N., et al. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo. Curr. Biol. 27 (2017), 784–794.
62. +repletion. Sci. Rep., 7, 2017, 2268.
63. Dietrich, L.S., Fuller, L., Yero, I.L., Martinez, L., Nicotinamide mononucleotide pyrophosphorylase activity in animal tissues. J. Biol. Chem. 241 (1966), 188–191.
64. Dölle, C., Niere, M., Lohndal, E., Ziegler, M., Visualization of subcellular NAD pools and intra-organellar protein localization by poly-ADP-ribose formation. Cell. Mol. Life Sci. 67 (2010), 433–443.
65. Domergue, R., Castaño, I., De Las Peñas, A., Zupancic, M., Lockatell, V., Hebel, J.R., Johnson, D., Cormack, B.P., Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308 (2005), 866–870.
66. Dominy, J.E. Jr., Lee, Y., Jedrychowski, M.P., Chim, H., Jurczak, M.J., Camporez, J.P., Ruan, H.B., Feldman, J., Pierce, K., Mostoslavsky, R., et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell 48 (2012), 900–913.
67. Dower, J.I., Geleijnse, J.M., Gijsbers, L., Zock, P.L., Kromhout, D., Hollman, P.C., Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 101 (2015), 914–921.
68. Du, J., Zhou, Y., Su, X., Yu, J.J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J.H., Choi, B.H., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334 (2011), 806–809.
69. Duarte-Pereira, S., Pereira-Castro, I., Silva, S.S., Correia, M.G., Neto, C., da Costa, L.T., Amorim, A., Silva, R.M., Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors. Oncotarget 7 (2016), 1973–1983.
70. Dutca, L.M., Stasheff, S.F., Hedberg-Buenz, A., Rudd, D.S., Batra, N., Blodi, F.R., Yorek, M.S., Yin, T., Shankar, M., Herlein, J.A., et al. Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243. Invest. Ophthalmol. Vis. Sci. 55 (2014), 8330–8341.
71. Escande, C., Nin, V., Price, N.L., Capellini, V., Gomes, A.P., Barbosa, M.T., O'Neil, L., White, T.A., Sinclair, D.A., Chini, E.N., Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 62 (2013), 1084–1093.
72. Essuman, K., Summers, D.W., Sasaki, Y., Mao, X., DiAntonio, A., Milbrandt, J., The SARM1 Toll/Interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration. Neuron 93 (2017), 1334–1343.e5.
73. Evans, T., Matulonis, U., PARP inhibitors in ovarian cancer: evidence, experience and clinical potential. Ther. Adv. Med. Oncol. 9 (2017), 253–267.
74. Fall, P.A., Fredrikson, M., Axelson, O., Granérus, A.K., Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov. Disord. 14 (1999), 28–37.
75. Fang, E.F., Scheibye-Knudsen, M., Brace, L.E., Kassahun, H., SenGupta, T., Nilsen, H., Mitchell, J.R., Croteau, D.L., Bohr, V.A., Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 157 (2014), 882–896.
76. +Replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA Repair. Cell Metab. 24 (2016), 566–581.
77. Finley, L.W., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P.I., Cardoso, S.M., Clish, C.B., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19 (2011), 416–428.
78. Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One, 3, 2008, e2020.
79. Fletcher, R.S., Ratajczak, J., Doig, C.L., Oakey, L.A., Callingham, R., Da Silva Xavier, G., Garten, A., Elhassan, Y.S., Redpath, P., Migaud, M.E., et al. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Mol. Metab. 6 (2017), 819–832.
80. Frederick, D.W., Davis, J.G., Dávila, A. Jr., Agarwal, B., Michan, S., Puchowicz, M.A., Nakamaru-Ogiso, E., Baur, J.A., Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism. J. Biol. Chem. 290 (2015), 1546–1558.
81. Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A.L., Munn, D.H., Antonia, S.J., Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer 101 (2002), 151–155.
82. Friebe, D., Neef, M., Kratzsch, J., Erbs, S., Dittrich, K., Garten, A., Petzold-Quinque, S., Blüher, S., Reinehr, T., Stumvoll, M., et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 54 (2011), 1200–1211.
83. Frydelund-Larsen, L., Akerstrom, T., Nielsen, S., Keller, P., Keller, C., Pedersen, B.K., Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. Am. J. Physiol. Endocrinol. Metab. 292 (2007), E24–E31.
84. Frye, R.A., Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260 (1999), 273–279.
85. Garg, A., Sharma, A., Krishnamoorthy, P., Garg, J., Virmani, D., Sharma, T., Stefanini, G., Kostis, J.B., Mukherjee, D., Sikorskaya, E., Role of Niacin in current clinical practice: a systematic review. Am. J. Med. 130 (2017), 173–187.
86. Gariani, K., Menzies, K.J., Ryu, D., Wegner, C.J., Wang, X., Ropelle, E.R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 63 (2016), 1190–1204.
87. Gariani, K., Ryu, D., Menzies, K.J., Yi, H.S., Stein, S., Zhang, H., Perino, A., Lemos, V., Katsyuba, E., Jha, P., et al. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. J. Hepatol. 66 (2017), 132–141.
88. Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., Kiess, W., Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat. Rev. Endocrinol. 11 (2015), 535–546.
89. Gensler, H.L., Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutr. Cancer 29 (1997), 157–162.
90. Geraets, L., Moonen, H.J., Brauers, K., Wouters, E.F., Bast, A., Hageman, G.J., Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J. Nutr. 137 (2007), 2190–2195.
91. Gerdts, J., Summers, D.W., Sasaki, Y., DiAntonio, A., Milbrandt, J., Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J. Neurosci. 33 (2013), 13569–13580.
92. + destruction. Science 348 (2015), 453–457.
93. Gertler, A.A., Cohen, H.Y., SIRT6, a protein with many faces. Biogerontology 14 (2013), 629–639.
94. Gilley, J., Orsomando, G., Nascimento-Ferreira, I., Coleman, M.P., Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Rep. 10 (2015), 1974–1981.
95. Gomes, A.P., Price, N.L., Ling, A.J., Moslehi, J.J., Montgomery, M.K., Rajman, L., White, J.P., Teodoro, J.S., Wrann, C.D., Hubbard, B.P., et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155 (2013), 1624–1638.
96. Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., Wang, J., Sastre, M., Ono, K., Sauve, A.A., Pasinetti, G.M., Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol. Aging 34 (2013), 1581–1588.
97. Goody, M.F., Kelly, M.W., Reynolds, C.J., Khalil, A., Crawford, B.D., Henry, C.A., NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy. PLoS Biol., 10, 2012, e1001409.
98. Gopal, E., Miyauchi, S., Martin, P.M., Ananth, S., Roon, P., Smith, S.B., Ganapathy, V., Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm. Res. 24 (2007), 575–584.
99. Grozio, A., Sociali, G., Sturla, L., Caffa, I., Soncini, D., Salis, A., Raffaelli, N., De Flora, A., Nencioni, A., Bruzzone, S., CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. J. Biol. Chem. 288 (2013), 25938–25949.
100. Grube, K., Bürkle, A., Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc. Natl. Acad. Sci. USA 89 (1992), 11759–11763.
101. +Precursor, rescues age-associated susceptibility to AKI in a Sirtuin 1-dependent manner. J. Am. Soc. Nephrol. 28 (2017), 2337–2352.
102. Gupte, R., Liu, Z., Kraus, W.L., PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 31 (2017), 101–126.
103. Haferkamp, I., Schmitz-Esser, S., Linka, N., Urbany, C., Collingro, A., Wagner, M., Horn, M., Neuhaus, H.E., A candidate NAD+ transporter in an intracellular bacterial symbiont related to Chlamydiae. Nature 432 (2004), 622–625.
104. Haffner, C.D., Becherer, J.D., Boros, E.E., Cadilla, R., Carpenter, T., Cowan, D., Deaton, D.N., Guo, Y., Harrington, W., Henke, B.R., et al. Discovery, synthesis, and biological evaluation of Thiazoloquin(az)olin(on)es as potent CD38 inhibitors. J. Med. Chem. 58 (2015), 3548–3571.
105. Hafner, A.V., Dai, J., Gomes, A.P., Xiao, C.Y., Palmeira, C.M., Rosenzweig, A., Sinclair, D.A., Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2 (2010), 914–923.
106. Haider, D.G., Holzer, G., Schaller, G., Weghuber, D., Widhalm, K., Wagner, O., Kapiotis, S., Wolzt, M., The adipokine visfatin is markedly elevated in obese children. J. Pediatr. Gastroenterol. Nutr. 43 (2006), 548–549.
107. Haigis, M.C., Sinclair, D.A., Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5 (2010), 253–295.
108. Haigis, M.C., Mostoslavsky, R., Haigis, K.M., Fahie, K., Christodoulou, D.C., Murphy, A.J., Valenzuela, D.M., Yancopoulos, G.D., Karow, M., Blander, G., et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126 (2006), 941–954.
109. Haikarainen, T., Krauss, S., Lehtio, L., Tankyrases: structure, function and therapeutic implications in cancer. Curr. Pharm. Des. 20 (2014), 6472–6488.
110. Hallschmid, M., Randeva, H., Tan, B.K., Kern, W., Lehnert, H., Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 58 (2009), 637–640.
111. Hamity, M.V., White, S.R., Walder, R.Y., Schmidt, M.S., Brenner, C., Hammond, D.L., Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats. Pain 158 (2017), 962–972.
112. Hara, N., Yamada, K., Shibata, T., Osago, H., Hashimoto, T., Tsuchiya, M., Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J. Biol. Chem. 282 (2007), 24574–24582.
113. Hara, N., Yamada, K., Shibata, T., Osago, H., Tsuchiya, M., Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS One, 6, 2011, e22781.
114. Harden, A., Young, W.J., The Alcoholic Ferment of Yeast-Juice Part II.–The coferment of yeast-juice. Proc. R. Soc. Lond. B Biol. Sci 78 (1906), 369–375.
115. Heilbronn, L.K., Clinical trials corner. Nutr Healthy Aging 4 (2017), 265–266.
116. Hellenbrand, W., Boeing, H., Robra, B.P., Seidler, A., Vieregge, P., Nischan, P., Joerg, J., Oertel, W.H., Schneider, E., Ulm, G., Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 47 (1996), 644–650.
117. Hernández-Campo, P.M., Almeida, J., Sánchez, M.L., Malvezzi, M., Orfao, A., Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin. Cytom. 70 (2006), 71–81.
118. Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B., Grueter, C.A., Harris, C., Biddinger, S., Ilkayeva, O.R., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464 (2010), 121–125.
119. Hoffer, A., Prousky, J., Successful treatment of schizophrenia requires optimal daily doses of vitamin B3. Altern. Med. Rev. 13 (2008), 287–291.
120. Horton, J.L., Martin, O.J., Lai, L., Riley, N.M., Richards, A.L., Vega, R.B., Leone, T.C., Pagliarini, D.J., Muoio, D.M., Bedi, K.C. Jr., et al. Mitochondrial protein hyperacetylation in the failing heart. JCI Insight, 2, 2016, e84897.
121. +supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc. Natl. Acad. Sci. USA, 2018, 10.1073/pnas.1718819115 Published online February 5, 2018.
122. Hsu, C.P., Oka, S., Shao, D., Hariharan, N., Sadoshima, J., Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ. Res. 105 (2009), 481–491.
123. Huang, S.M., Mishina, Y.M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G.A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461 (2009), 614–620.
124. Huang, J.Y., Wang, K., Vermehren-Schmaedick, A., Adelman, J.P., Cohen, M.S., PARP6 is a regulator of hippocampal dendritic morphogenesis. Sci. Rep., 6, 2016, 18512.
125. Imai, S., Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr. Pharm. Des. 15 (2009), 20–28.
126. Imai, S., Guarente, L., NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24 (2014), 464–471.
127. Imai, S., Yoshino, J., The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes. Metab. 15:Suppl 3 (2013), 26–33.
128. Imai, S., Armstrong, C.M., Kaeberlein, M., Guarente, L., Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000), 795–800.
129. Ivy, J.M., Hicks, J.B., Klar, A.J., Map positions of yeast genes SIR1, SIR3 and SIR4. Genetics 111 (1985), 735–744.
130. Iwata, H., Goettsch, C., Sharma, A., Ricchiuto, P., Goh, W.W., Halu, A., Yamada, I., Yoshida, H., Hara, T., Wei, M., et al. PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation. Nat. Commun., 7, 2016, 12849.
131. Jia, H., Li, X., Gao, H., Feng, Z., Li, X., Zhao, L., Jia, X., Zhang, H., Liu, J., High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease. J. Neurosci. Res. 86 (2008), 2083–2090.
132. Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.L., Zhao, S., Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 43 (2011), 33–44.
133. Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., et al. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496 (2013), 110–113.
134. Jwa, M., Chang, P., PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein response. Nat. Cell Biol. 14 (2012), 1223–1230.
135. Kanai, Y., Segawa, H., Miyamoto, Ki., Uchino, H., Takeda, E., Endou, H., Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273 (1998), 23629–23632.
136. Kaneko, S., Wang, J., Kaneko, M., Yiu, G., Hurrell, J.M., Chitnis, T., Khoury, S.J., He, Z., Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 26 (2006), 9794–9804.
137. Karamanlidis, G., Lee, C.F., Garcia-Menendez, L., Kolwicz, S.C. Jr., Suthammarak, W., Gong, G., Sedensky, M.M., Morgan, P.G., Wang, W., Tian, R., Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab. 18 (2013), 239–250.
138. Katske, F., Shoskes, D.A., Sender, M., Poliakin, R., Gagliano, K., Rajfer, J., Treatment of interstitial cystitis with a quercetin supplement. Tech. Urol. 7 (2001), 44–46.
139. Kellenberger, E., Kuhn, I., Schuber, F., Muller-Steffner, H., Flavonoids as inhibitors of human CD38. Bioorg. Med. Chem. Lett. 21 (2011), 3939–3942.
140. Kickhoefer, V.A., Siva, A.C., Kedersha, N.L., Inman, E.M., Ruland, C., Streuli, M., Rome, L.H., The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J. Cell Biol. 146 (1999), 917–928.
141. Kirchberger, T., Guse, A.H., Measuring CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) activity by reverse-phase HPLC. Cold Spring Harb. Protoc. 2013 (2013), 569–573.
142. Klaidman, L., Morales, M., Kem, S., Yang, J., Chang, M.-L., Adams, J.D. Jr., Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 69 (2003), 150–157.
143. Koedel, U., Winkler, F., Angele, B., Fontana, A., Pfister, H.W., Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 22 (2002), 39–49.
144. Körner, A., Garten, A., Blüher, M., Tauscher, R., Kratzsch, J., Kiess, W., Molecular characteristics of serum visfatin and differential detection by immunoassays. J. Clin. Endocrinol. Metab. 92 (2007), 4783–4791.
145. Kraus, D., Yang, Q., Kong, D., Banks, A.S., Zhang, L., Rodgers, J.T., Pirinen, E., Pulinilkunnil, T.C., Gong, F., Wang, Y.C., et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508 (2014), 258–262.
146. Landry, J., Sutton, A., Tafrov, S.T., Heller, R.C., Stebbins, J., Pillus, L., Sternglanz, R., The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA 97 (2000), 5807–5811.
147. Lee, J.S., Cha, Y.J., Lee, K.H., Yim, J.E., Onion peel extract reduces the percentage of body fat in overweight and obese subjects: a 12-week, randomized, double-blind, placebo-controlled study. Nutr. Res. Pract. 10 (2016), 175–181.
148. Lee, M.K., Cheong, H.S., Koh, Y., Ahn, K.S., Yoon, S.S., Shin, H.D., Genetic association of PARP15 polymorphisms with clinical outcome of acute myeloid leukemia in a Korean population. Genet. Test. Mol. Biomarkers 20 (2016), 696–701.
149. Leung, A.K., Vyas, S., Rood, J.E., Bhutkar, A., Sharp, P.A., Chang, P., Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell 42 (2011), 489–499.
150. +binding pocket that regulates protein-protein interactions during aging. Science 355 (2017), 1312–1317.
151. Lin, S.J., Ford, E., Haigis, M., Liszt, G., Guarente, L., Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 18 (2004), 12–16.
152. Lin, J.B., Kubota, S., Ban, N., Yoshida, M., Santeford, A., Sene, A., Nakamura, R., Zapata, N., Kubota, M., Tsubota, K., et al. NAMPT-mediated NAD(+) biosynthesis is essential for vision in mice. Cell Rep. 17 (2016), 69–85.
153. Liszt, G., Ford, E., Kurtev, M., Guarente, L., Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280 (2005), 21313–21320.
154. Liu, C., Yu, X., ADP-ribosyltransferases and poly ADP-ribosylation. Curr. Protein Pept. Sci. 16 (2015), 491–501.
155. Long, A.N., Owens, K., Schlappal, A.E., Kristian, T., Fishman, P.S., Schuh, R.A., Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. BMC Neurol., 15, 2015, 19.
156. Ma, B., Pan, S.J., Zupancic, M.L., Cormack, B.P., Assimilation of NAD(+) precursors in Candida glabrata. Mol. Microbiol. 66 (2007), 14–25.
157. Magni, G., Amici, A., Emanuelli, M., Raffaelli, N., Ruggieri, S., Enzymology of NAD+ synthesis. Adv. Enzymol. Relat. Areas Mol. Biol. 73 (1999), 135–182 xi.
158. Magni, G., Amici, A., Emanuelli, M., Orsomando, G., Raffaelli, N., Ruggieri, S., Enzymology of NAD+ homeostasis in man. Cell. Mol. Life Sci. 61 (2004), 19–34.
159. Majamaa, K., Rusanen, H., Remes, A.M., Pyhtinen, J., Hassinen, I.E., Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome. Life Sci. 58 (1996), 691–699.
160. Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A.L., Ortolan, E., Vaisitti, T., Aydin, S., Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 88 (2008), 841–886.
161. Malyuchenko, N.V., Kotova, E.Y., Kulaeva, O.I., Kirpichnikov, M.P., Studitskiy, V.M., PARP1 Inhibitors: antitumor drug design. Acta Naturae 7 (2015), 27–37.
162. Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A., Gorbunova, V., SIRT6 promotes DNA repair under stress by activating PARP1. Science 332 (2011), 1443–1446.
163. Martin, A.S., Abraham, D.M., Hershberger, K.A., Bhatt, D.P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M.J., Grimsrud, P.A., et al. Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model. JCI Insight, 2, 2017, 10.1172/jci.insight.93885 Published online July 20, 2017.
164. Masri, S., Rigor, P., Cervantes, M., Ceglia, N., Sebastian, C., Xiao, C., Roqueta-Rivera, M., Deng, C., Osborne, T.F., Mostoslavsky, R., et al. Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158 (2014), 659–672.
165. Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B., Guillemin, G.J., Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 7, 2012, e42357.
166. Mathews, M.T., Berk, B.C., PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 711–717.
167. Menezes, R., Rodriguez-Mateos, A., Kaltsatou, A., González-Sarrías, A., Greyling, A., Giannaki, C., Andres-Lacueva, C., Milenkovic, D., Gibney, E.R., Dumont, J., et al. Impact of flavonols on cardiometabolic biomarkers: a meta-analysis of randomized controlled human trials to explore the role of inter-individual variability. Nutrients, 9, 2017, E117.
168. Mercader, J., Granados, N., Caimari, A., Oliver, P., Bonet, M.L., Palou, A., Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models. Horm. Metab. Res. 40 (2008), 467–472.
169. Meyer-Ficca, M.L., Ihara, M., Bader, J.J., Leu, N.A., Beneke, S., Meyer, R.G., Spermatid head elongation with normal nuclear shaping requires ADP-ribosyltransferase PARP11 (ARTD11) in mice. Biol. Reprod., 92, 2015, 80.
170. Mills, K.F., Yoshida, S., Stein, L.R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M.E., Apte, R.S., Uchida, K., et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 24 (2016), 795–806.
171. Moreira, D., Rodrigues, V., Abengozar, M., Rivas, L., Rial, E., Laforge, M., Li, X., Foretz, M., Viollet, B., Estaquier, J., et al. Leishmania infantum modulates host macrophage mitochondrial metabolism by hijacking the SIRT1-AMPK axis. PLoS Pathog., 11, 2015, e1004684.
172. Mori, V., Amici, A., Mazzola, F., Di Stefano, M., Conforti, L., Magni, G., Ruggieri, S., Raffaelli, N., Orsomando, G., Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues. PLoS One, 9, 2014, e113939.
173. Morigi, M., Perico, L., Rota, C., Longaretti, L., Conti, S., Rottoli, D., Novelli, R., Remuzzi, G., Benigni, A., Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J. Clin. Invest. 125 (2015), 715–726.
174. Morris, M.C., Evans, D.A., Bienias, J.L., Scherr, P.A., Tangney, C.C., Hebert, L.E., Bennett, D.A., Wilson, R.S., Aggarwal, N., Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J. Neurol. Neurosurg. Psychiatry 75 (2004), 1093–1099.
175. Mouchiroud, L., Houtkooper, R.H., Moullan, N., Katsyuba, E., Ryu, D., Cantó C., Mottis, A., Jo, Y.S., Viswanathan, M., Schoonjans, K., et al. The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154 (2013), 430–441.
176. Mukherjee, S., Chellappa, K., Moffitt, A., Ndungu, J., Dellinger, R.W., Davis, J.G., Agarwal, B., Baur, J.A., Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration. Hepatology 65 (2017), 616–630.
177. Muller, A.J., DuHadaway, J.B., Donover, P.S., Sutanto-Ward, E., Prendergast, G.C., Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11 (2005), 312–319.
178. Murray, M.F., Nghiem, M., Srinivasan, A., HIV infection decreases intracellular nicotinamide adenine dinucleotide [NAD]. Biochem. Biophys. Res. Commun. 212 (1995), 126–131.
179. Nagy, Z., Kalousi, A., Furst, A., Koch, M., Fischer, B., Soutoglou, E., Tankyrases promote homologous recombination and check point activation in response to DSBs. PLoS Genet., 12, 2016, e1005791.
180. Nichols, M., Townsend, N., Scarborough, P., Rayner, M., Cardiovascular disease in Europe 2014: epidemiological update. Eur. Heart J., 35, 2014, 2929.
181. Nikiforov, A., Dölle, C., Niere, M., Ziegler, M., Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 286 (2011), 21767–21778.
182. Niren, N.M., Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. Cutis 77:1 Suppl (2006), 11–16.
183. North, B.J., Rosenberg, M.A., Jeganathan, K.B., Hafner, A.V., Michan, S., Dai, J., Baker, D.J., Cen, Y., Wu, L.E., Sauve, A.A., et al. SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J. 33 (2014), 1438–1453.
184. Osterloh, J.M., Yang, J., Rooney, T.M., Fox, A.N., Adalbert, R., Powell, E.H., Sheehan, A.E., Avery, M.A., Hackett, R., Logan, M.A., et al. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337 (2012), 481–484.
185. Park, J.H., Long, A., Owens, K., Kristian, T., Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia. Neurobiol. Dis. 95 (2016), 102–110.
186. Partidá-Sánchez, S., Rivero-Nava, L., Shi, G., Lund, F.E., CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses. Adv. Exp. Med. Biol. 590 (2007), 171–183.
187. Pfeuffer, M., Auinger, A., Bley, U., Kraus-Stojanowic, I., Laue, C., Winkler, P., Rüfer, C.E., Frank, J., Bösch-Saadatmandi, C., Rimbach, G., Schrezenmeir, J., Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr. Metab. Cardiovasc. Dis. 23 (2013), 403–409.
188. Phelan, M.J., Mulnard, R.A., Gillen, D.L., Schreiber, S.S., Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer's disease. J. Geriatr. Med. Gerontol., 3, 2017, 10.23937/2469-5858/1510021.
189. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M.W., Guarente, L., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429 (2004), 771–776.
190. Pieper, A.A., Xie, S., Capota, E., Estill, S.J., Zhong, J., Long, J.M., Becker, G.L., Huntington, P., Goldman, S.E., Shen, C.H., et al. Discovery of a proneurogenic, neuroprotective chemical. Cell 142 (2010), 39–51.
191. Pillai, J.B., Isbatan, A., Imai, S., Gupta, M.P., Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem. 280 (2005), 43121–43130.
192. Pillai, V.B., Sundaresan, N.R., Kim, G., Samant, S., Moreno-Vinasco, L., Garcia, J.G., Gupta, M.P., Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling. Am. J. Physiol. Heart Circ. Physiol. 304 (2013), H415–H426.
193. Pirinen, E., Cantó C., Jo, Y.S., Morato, L., Zhang, H., Menzies, K.J., Williams, E.G., Mouchiroud, L., Moullan, N., Hagberg, C., et al. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 19 (2014), 1034–1041.
194. Poljsak, B., NAD+ in cancer prevention and treatment: pros and cons. J. Clin. Exp. Oncol., 5, 2016, 10.4172/2324-9110.1000165.
195. Premkumar, V.G., Yuvaraj, S., Vijayasarathy, K., Gangadaran, S.G., Sachdanandam, P., Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy. Biol. Pharm. Bull. 30 (2007), 367–370.
196. Quarona, V., Zaccarello, G., Chillemi, A., Brunetti, E., Singh, V.K., Ferrero, E., Funaro, A., Horenstein, A.L., Malavasi, F., CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin. Cytom. 84 (2013), 207–217.
197. Ramsey, K.M., Yoshino, J., Brace, C.S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.K., Chong, J.L., Buhr, E.D., Lee, C., et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324 (2009), 651–654.
198. Rappou, E., Jukarainen, S., Rinnankoski-Tuikka, R., Kaye, S., Heinonen, S., Hakkarainen, A., Lundbom, J., Lundbom, N., Saunavaara, V., Rissanen, A., et al. Weight loss is associated with increased NAD(+)/SIRT1 expression but reduced PARP activity in white adipose tissue. J. Clin. Endocrinol. Metab. 101 (2016), 1263–1273.
199. Ratajczak, J., Joffraud, M., Trammell, S.A., Ras, R., Canela, N., Boutant, M., Kulkarni, S.S., Rodrigues, M., Redpath, P., Migaud, M.E., et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun., 7, 2016, 13103.
200. Ren, J.H., Tao, Y., Zhang, Z.Z., Chen, W.X., Cai, X.F., Chen, K., Ko, B.C., Song, C.L., Ran, L.K., Li, W.Y., et al. Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1. J. Virol. 88 (2014), 2442–2451.
201. Rennie, G., Chen, A.C., Dhillon, H., Vardy, J., Damian, D.L., Nicotinamide and neurocognitive function. Nutr. Neurosci. 18 (2015), 193–200.
202. Revollo, J.R., Grimm, A.A., Imai, S., The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr. Opin. Gastroenterol. 23 (2007), 164–170.
203. Revollo, J.R., Körner, A., Mills, K.F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R.R., et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6 (2007), 363–375.
204. Rine, J., Herskowitz, I., Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics 116 (1987), 9–22.
205. Rivin, A.U., Hypercholesterolemia. Use of niacin and niacin combinations in therapy. Calif. Med. 96 (1962), 267–269.
206. Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., Puigserver, P., Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434 (2005), 113–118.
207. Rolfe, H.M., A review of nicotinamide: treatment of skin diseases and potential side effects. J. Cosmet. Dermatol. 13 (2014), 324–328.
208. Rulten, S.L., Fisher, A.E., Robert, I., Zuma, M.C., Rouleau, M., Ju, L., Poirier, G., Reina-San-Martin, B., Caldecott, K.W., PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol. Cell 41 (2011), 33–45.
209. Ryu, D., Zhang, H., Ropelle, E.R., Sorrentino, V., Mázala, D.A., Mouchiroud, L., Marshall, P.L., Campbell, M.D., Ali, A.S., Knowels, G.M., et al. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci. Transl. Med., 8, 2016, 361ra139.
210. Sadanaga-Akiyoshi, F., Yao, H., Tanuma, S., Nakahara, T., Hong, J.S., Ibayashi, S., Uchimura, H., Fujishima, M., Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra. Neurochem. Res. 28 (2003), 1227–1234.
211. Saddi-Rosa, P., Oliveira, C., Crispim, F., Giuffrida, F.M., de Lima, V., Vieira, J., Doria, A., Velho, G., Reis, A., Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects. Cardiovasc. Diabetol., 12, 2013, 119.
212. Santidrian, A.F., Matsuno-Yagi, A., Ritland, M., Seo, B.B., LeBoeuf, S.E., Gay, L.J., Yagi, T., Felding-Habermann, B., Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J. Clin. Invest. 123 (2013), 1068–1081.
213. +depletion. Elife, 5, 2016, e19749.
214. Schreiber, V., Amé J.C., Dollé P., Schultz, I., Rinaldi, B., Fraulob, V., Ménissier-de Murcia, J., de Murcia, G., Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J. Biol. Chem. 277 (2002), 23028–23036.
215. Schuster, S., Penke, M., Gorski, T., Petzold-Quinque, S., Damm, G., Gebhardt, R., Kiess, W., Garten, A., Resveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes. PLoS One, 9, 2014, e91045.
216. Scoffone, H.M., Krajewski, M., Zorca, S., Bereal-Williams, C., Littel, P., Seamon, C., Mendelsohn, L., Footman, E., Abi-Jaoudeh, N., Sachdev, V., et al. Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels. Am. J. Cardiol. 112 (2013), 1499–1504.
217. Sebastián, C., Zwaans, B.M., Silberman, D.M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A.R., Toiber, D., et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151 (2012), 1185–1199.
218. Sharif, T., Ahn, D.G., Liu, R.Z., Pringle, E., Martell, E., Dai, C., Nunokawa, A., Kwak, M., Clements, D., Murphy, J.P., et al. The NAD(+) salvage pathway modulates cancer cell viability via p73. Cell Death Differ. 23 (2016), 669–680.
219. Shimazu, T., Hirschey, M.D., Hua, L., Dittenhafer-Reed, K.E., Schwer, B., Lombard, D.B., Li, Y., Bunkenborg, J., Alt, F.W., Denu, J.M., et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12 (2010), 654–661.
220. Shukla, S., Bhaskaran, N., Babcook, M.A., Fu, P., Maclennan, G.T., Gupta, S., Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis 35 (2014), 452–460.
221. Someya, S., Yu, W., Hallows, W.C., Xu, J., Vann, J.M., Leeuwenburgh, C., Tanokura, M., Denu, J.M., Prolla, T.A., Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143 (2010), 802–812.
222. +glioblastoma tumor-initiating cells. Exp. Mol. Med., 49, 2017, e344.
223. Sorrentino, V., Romani, M., Mouchiroud, L., Beck, J.S., Zhang, H., D'Amico, D., Moullan, N., Potenza, F., Schmid, A.W., Rietsch, S., et al. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity. Nature 552 (2017), 187–193.
224. Summers, D.W., Gibson, D.A., DiAntonio, A., Milbrandt, J., SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation. Proc. Natl. Acad. Sci. USA 113 (2016), E6271–E6280.
225. Sundaresan, N.R., Gupta, M., Kim, G., Rajamohan, S.B., Isbatan, A., Gupta, M.P., Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119 (2009), 2758–2771.
226. Tanner, K.G., Landry, J., Sternglanz, R., Denu, J.M., Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. USA 97 (2000), 14178–14182.
227. Tesla, R., Wolf, H.P., Xu, P., Drawbridge, J., Estill, S.J., Huntington, P., McDaniel, L., Knobbe, W., Burket, A., Tran, S., et al. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 109 (2012), 17016–17021.
228. Trammell, S.A., Schmidt, M.S., Weidemann, B.J., Redpath, P., Jaksch, F., Dellinger, R.W., Li, Z., Abel, E.D., Migaud, M.E., Brenner, C., Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun., 7, 2016, 12948.
229. Trammell, S.A., Yu, L., Redpath, P., Migaud, M.E., Brenner, C., Nicotinamide riboside is a major NAD+ precursor vitamin in cow milk. J. Nutr. 146 (2016), 957–963.
230. Tran, M.T., Zsengeller, Z.K., Berg, A.H., Khankin, E.V., Bhasin, M.K., Kim, W., Clish, C.B., Stillman, I.E., Karumanchi, S.A., Rhee, E.P., Parikh, S.M., PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531 (2016), 528–532.
231. Tsilioni, I., Taliou, A., Francis, K., Theoharides, T.C., Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl. Psychiatry, 5, 2015, e647.
232. Tsubota, K., The first human clinical study for NMN has started in Japan. NPJ Aging Mech Dis, 2, 2016, 16021.
233. Tummala, K.S., Gomes, A.L., Yilmaz, M., Graña, O., Bakiri, L., Ruppen, I., Ximénez-Embún, P., Sheshappanavar, V., Rodriguez-Justo, M., Pisano, D.G., et al. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell 26 (2014), 826–839.
234. Ugur, S., Ulu, R., Dogukan, A., Gurel, A., Yigit, I.P., Gozel, N., Aygen, B., Ilhan, N., The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Ren. Fail. 37 (2015), 332–336.
235. Ummarino, S., Mozzon, M., Zamporlini, F., Amici, A., Mazzola, F., Orsomando, G., Ruggieri, S., Raffaelli, N., Simultaneous quantitation of nicotinamide riboside, nicotinamide mononucleotide and nicotinamide adenine dinucleotide in milk by a novel enzyme-coupled assay. Food Chem. 221 (2017), 161–168.
236. Ungvari, Z., Kaley, G., de Cabo, R., Sonntag, W.E., Csiszar, A., Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65 (2010), 1028–1041.
237. Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., Van den Eynde, B.J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9 (2003), 1269–1274.
238. Vaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M.S., Vivien, D., Orset, C., Jacotot, E., Brenner, C., Duplus, E., Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration. FASEB J. 31 (2017), 5440–5452.
239. Verheugd, P., Forst, A.H., Milke, L., Herzog, N., Feijs, K.L., Kremmer, E., Kleine, H., Lüscher, B., Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10. Nat. Commun., 4, 2013, 1683.
240. Wang, G., Han, T., Nijhawan, D., Theodoropoulos, P., Naidoo, J., Yadavalli, S., Mirzaei, H., Pieper, A.A., Ready, J.M., McKnight, S.L., P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage. Cell 158 (2014), 1324–1334.
241. Wang, X., Hu, X., Yang, Y., Takata, T., Sakurai, T., Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res. 1643 (2016), 1–9.
242. Warburg, O., Christian, W., Pyridin, the hydrogen-transferring component of the fermentation enzymes (pyridine nucleotide). Biochem. Z., 287, 1936, 291.
243. Wei, C.C., Kong, Y.Y., Hua, X., Li, G.Q., Zheng, S.L., Cheng, M.H., Wang, P., Miao, C.Y., NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia. Br. J. Pharmacol. 174 (2017), 3823–3836.
244. Wei, C.C., Kong, Y.Y., Li, G.Q., Guan, Y.F., Wang, P., Miao, C.Y., Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway. Sci. Rep., 7, 2017, 717.
245. Wencel, P.L., Lukiw, W.J., Strosznajder, J.B., Strosznajder, R.P., Inhibition of Poly(ADP-ribose) Polymerase-1 enhances gene expression of selected Sirtuins and APP cleaving enzymes in amyloid beta cytotoxicity. Mol. Neurobiol., 2017, 10.1007/s12035-017-0646-8 Published online July 12, 2017.
246. Widner, B., Leblhuber, F., Fuchs, D., Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. J Neural Transm (Vienna) 109 (2002), 181–189.
247. Wu, L.E., Gomes, A.P., Sinclair, D.A., Geroncogenesis: metabolic changes during aging as a driver of tumorigenesis. Cancer Cell 25 (2014), 12–19.
248. Xu, W., Barrientos, T., Mao, L., Rockman, H.A., Sauve, A.A., Andrews, N.C., Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep. 13 (2015), 533–545.
249. Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., Sadoshima, J., Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS One, 9, 2014, e98972.
250. Yan, T., Feng, Y., Zheng, J., Ge, X., Zhang, Y., Wu, D., Zhao, J., Zhai, Q., Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity. Neurochem. Int. 56 (2010), 101–106.
251. Yang, F., Vought, B.W., Satterlee, J.S., Walker, A.K., Jim Sun, Z.Y., Watts, J.L., DeBeaumont, R., Saito, R.M., Hyberts, S.G., Yang, S., et al. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442 (2006), 700–704.
252. Yang, H., Yang, T., Baur, J.A., Perez, E., Matsui, T., Carmona, J.J., Lamming, D.W., Souza-Pinto, N.C., Bohr, V.A., Rosenzweig, A., et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130 (2007), 1095–1107.
253. Yang, D., Elner, S.G., Chen, X., Field, M.G., Petty, H.R., Elner, V.M., MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 52 (2011), 6026–6034.
254. Yiasemides, E., Sivapirabu, G., Halliday, G.M., Park, J., Damian, D.L., Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis 30 (2009), 101–105.
255. Yin, T.C., Britt, J.K., De Jesús-Cortés, H., Lu, Y., Genova, R.M., Khan, M.Z., Voorhees, J.R., Shao, J., Katzman, A.C., Huntington, P.J., et al. P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury. Cell Rep. 8 (2014), 1731–1740.
256. Yoshino, J., Mills, K.F., Yoon, M.J., Imai, S., Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14 (2011), 528–536.
257. Zamporlini, F., Ruggieri, S., Mazzola, F., Amici, A., Orsomando, G., Raffaelli, N., Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells. FEBS J. 281 (2014), 5104–5119.
258. Zerez, C.R., Roth, E.F. Jr., Schulman, S., Tanaka, K.R., Increased nicotinamide adenine dinucleotide content and synthesis in Plasmodium falciparum-infected human erythrocytes. Blood 75 (1990), 1705–1710.
259. Zhang, R.Y., Qin, Y., Lv, X.Q., Wang, P., Xu, T.Y., Zhang, L., Miao, C.Y., A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase. Anal. Biochem. 412 (2011), 18–25.
260. Zhang, T., Berrocal, J.G., Yao, J., DuMond, M.E., Krishnakumar, R., Ruhl, D.D., Ryu, K.W., Gamble, M.J., Kraus, W.L., Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase. J. Biol. Chem. 287 (2012), 12405–12416.
261. Zhang, P., Tu, B., Wang, H., Cao, Z., Tang, M., Zhang, C., Gu, B., Li, Z., Wang, L., Yang, Y., et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc. Natl. Acad. Sci. USA 111 (2014), 10684–10689.
262. + repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352 (2016), 1436–1443.
263. Zhou, T., Kurnasov, O., Tomchick, D.R., Binns, D.D., Grishin, N.V., Marquez, V.E., Osterman, A.L., Zhang, H., Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin. J. Biol. Chem. 277 (2002), 13148–13154.
264. Zhou, M., Ottenberg, G., Sferrazza, G.F., Hubbs, C., Fallahi, M., Rumbaugh, G., Brantley, A.F., Lasmézas, C.I., Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment. Brain 138 (2015), 992–1008.
265. Zhou, C.C., Yang, X., Hua, X., Liu, J., Fan, M.B., Li, G.Q., Song, J., Xu, T.Y., Li, Z.Y., Guan, Y.F., et al. Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. Br. J. Pharmacol. 173 (2016), 2352–2368.
266. Zhu, X.H., Lu, M., Lee, B.Y., Ugurbil, K., Chen, W., In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc. Natl. Acad. Sci. USA 112 (2015), 2876–2881.
267. Zhuo, L., Fu, B., Bai, X., Zhang, B., Wu, L., Cui, J., Cui, S., Wei, R., Chen, X., Cai, G., NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell. Physiol. Biochem. 27 (2011), 681–690.
268. Ziegler, M., Oei, S.L., A cellular survival switch: poly(ADP-ribosyl)ation stimulates DNA repair and silences transcription. BioEssays 23 (2001), 543–548.